Brief: Owens & Minor Q3 Adjusted EPS USD 0.42 Vs. IBES Estimate USD 0.41
04/11/2024 11:30
Nov 04 (Reuters) - Owens & Minor Q3 adjusted net income USD 33.2 million vs. IBES estimate USD 32.8 million. * Q3 adjusted operating income USD 84.2 million * Q3 revenue USD 2,721 million vs. IBES estimate USD 2,681 million * Q3 adjusted EBITDA USD 141.8 million vs. IBES estimate USD 144.7 million * Q3 net income USD -12.8 million * outlook FY adjusted EPS USD 1.45-1.55 * outlook FY revenue USD 10,600-10,800 million * outlook FY adjusted EBITDA USD 540-550 million
Recent news on Accendra Health
See all newsBrief: Accendra Health Receives Continued Listing Standard Notice From NYSE
Brief: Accendra Health Names Kenneth Gardner-Smith As President And Chief Executive Officer
U.S. RESEARCH ROUNDUP-Accendra Health, Celestica, Sionna Therapeutics
Accendra Health Inc reports results for the quarter ended June 30 - Earnings Summary
Accendra Health Q2 profit, revenue miss estimates on large payor exit